Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 7Head & Neck 3Breast 3Thoracic 2Sarcoma 2Gynecologic 2Gastrointestinal 2Myeloid 1Lymphoid 1Dermatologic 1CNS 1

Conditions

Lymphoma 103Precursor Cell Lymphoblastic Leukemia-Lymphoma 99Lymphoma, Non-Hodgkin 95Leukemia, Lymphocytic, Chronic, B-Cell 81Lymphoma, Large B-Cell, Diffuse 79Lymphoma, Follicular 65Multiple Myeloma 51Burkitt Lymphoma 49Lymphoma, B-Cell 48Hodgkin Disease 46Lymphoma, Mantle-Cell 43Recurrence 41Leukemia, Myeloid, Acute 40Neoplasms 34Leukemia 33Hematologic Neoplasms 29Myelodysplastic Syndromes 27Lymphoma, B-Cell, Marginal Zone 25Waldenstrom Macroglobulinemia 20Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 19Lymphoma, T-Cell 16Leukemia, B-Cell 16Lymphoma, Large-Cell, Anaplastic 15Sarcoma 13Lymphoma, T-Cell, Peripheral 13Leukemia, Myelogenous, Chronic, BCR-ABL Positive 13Leukemia, Biphenotypic, Acute 13Mycosis Fungoides 11Melanoma 10Lymphoma, T-Cell, Cutaneous 10

Interventions

temsirolimus 1Valproic Acid 1Sirolimus 1Immunoglobulin G 1Disulfides 1Cetuximab 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Urologic Neoplasms × Lymphoid × 30 days × Clear all
NCT01552434 2026-05-15

Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease

M.D. Anderson Cancer Center

Phase 1 Terminated
154 enrolled
BreastCNSGenitourinaryHead & NeckLymphoidMyeloidSarcoma

Breast Neoplasms, Carcinoma, Transitional Cell, Endocrine Gland Neoplasms, Castleman Disease, Mouth Neoplasms, Neoplasm Metastasis, Neoplasms, Pharyngeal Neoplasms, Recurrence, Sarcoma, Soft Tissue Neoplasms, Thyroid Neoplasms, Urologic Neoplasms, Neurofibromatosis 2, Lymphangioleiomyomatosis, Neoplasms, Mesothelial, Erdheim-Chester Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡